US Patent Issued to MEDIMMUNE, HUMABS BIOMED on June 10 for "Neutralizing anti-influenza B antibodies and uses thereof" (American, Swiss Inventors)

ALEXANDRIA, Va., June 18 -- United States Patent no. 12,325,740, issued on June 10, was assigned to MEDIMMUNE LLC (Gaithersburg, Md.) and HUMABS BIOMED SA (Bellinzona, Switzerland).

"Neutralizing anti-influenza B antibodies and uses thereof" was invented by Nicole Kallewaard-Lelay (Gaithersburg, Md.), Qing Zhu (Gaithersburg, Md.), Ebony Benjamin (Gaithersburg, Md.), Leslie Wachter (Gaithersburg, Md.), Andy Yuan (Monmouth, N.J.), Josephine Mary McAuliffe (Gaithersburg, Md.), Davide Corti (Bellinzona, Switzerland) and Antonio Lanzavecchia (Bellinzona, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to antibodies and antigen binding fragments thereof that are capable of binding ...